About Description

Wide coverage of hereditary cardiovascular disease-causing mutations
Superior technology that yields accurate results
Comprehensive reports
More effective clinical care
Painless, non-invasive sample collection

Cardiovascular Test (Ventrilia)

Regular price £150.00 ~~£189.00~~
Order within

To receive your order

Various cardiovascular diseases are inherited as they are the result of a genetic mutation. Most genetic mutations causing cardiovascular conditions are passed down in an autosomal dominant pattern. The autosomal dominant pattern means that inheriting only one copy of a mutated gene from one biological parent can cause disease. Therefore, there is a 50% chance of a child inheriting the same cardiovascular condition as the affected parent.

When a close family member is diagnosed with a hereditary cardiovascular disease, other family members should have genetic testing for earlier identification of the same genetic mutation.

WHAT IS Ventrilia?

Ventrilia is a new generation genetic test that screens for hereditary cardiovascular syndromes and diseases in individuals.

Ventrilia identifies numerous genetic changes (mutations) that cause multiple cardiovascular conditions with complex symptoms. Early identification of an underlying cardiovascular condition allows for timely intervention and can guide towards more effective treatment and management.

SYMPTOMS OF HEREDITARY CARDIOVASCULAR DISEASES:

Symptoms of hereditary cardiovascular diseases vary amongst affected individuals, with some experiencing mild to no symptoms, whereas others experience symptoms like:

Dizziness
Heart palpitations
Fainting
Shortness of breath
Fatigue
Chest pain

TREATMENT OF HEREDITARY:

Depending on the specific disease-causing genetic mutation and the cardiovascular condition.

Ventrilia Cardiovascular Test is a Buccal Swab

WHY CONSIDER Ventrilia?

Ventrilia can detect mutations that cause cardiovascular diseases and help your healthcare provider to choose an ideal treatment, develop a better clinical management plan and reduce the risk of sudden cardiovascular events, such as stroke or heart attack.

Additionally, Ventrilia can help identify at-risk family members who might be predisposed to hereditary cardiovascular diseases. For high-risk individuals with a cardiovascular genetic mutation that have not yet presented any symptoms, the healthcare provider can recommend appropriate examinations at key time intervals. Early intervention can potentially be lifesaving.